Purchases and Sales Made in Q1 2023 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q1 2023. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-182K- 16.08% |
$6.74M - $8.88M
|
951K
$40.5M
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-197K- 6.7% |
$7.29M - $9.6M
|
2.75M
$117M
|
|
|
May 15, 2023
Q1 2023
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-201K- 24.56% |
$7.42M - $9.78M
|
616K
$26.3M
|
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-553K- 13.49% |
$20.4M - $26.9M
|
3.54M
$151M
|
|
|
May 08, 2023
Q1 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-569K- 18.38% |
$21M - $27.7M
|
2.53M
$108M
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-669K- 60.06% |
$24.8M - $32.6M
|
445K
$19M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-669K- 60.06% |
$24.8M - $32.6M
|
445K
$19M
|
|
|
May 15, 2023
Q1 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-863K- 28.87% |
$31.9M - $42M
|
2.13M
$90.6M
|